The present application relates to sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol -1-yl)-1H-pyrazol-5-olate, to processes for its preparation, to its use for the treatment and/or prophylaxis of diseases and to its use for the preparation of medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing.本申請案係有關一種1-[6-(嗎啉-4-基)嘧啶-4-基]-4-(1H-1,2,3-三唑-1-基)-1H-吡唑-5-醇鈉，其製法，及其於治療及/或預防疾病上之用途，及其於製備醫藥上之用途，用於治療及/或預防疾病，特別是心血管與血液疾病，及腎臟疾病，及促進傷口癒合。
